Based on the results above, we can infer that OTUD6B-AS1 can regulate the activity of the Wnt/β-catenin signaling pathway and affect the expression of several EMT-related proteins in ccRCC cells. This evidence concerns the gene OTUD6B and nonpapillary renal cell carcinoma.